| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/26/2007 | EP1836208A2 AMINO-IMIDAZOLONES FOR THE INHIBITION OF ß-SECRETASE |
| 09/26/2007 | EP1836202A2 Aminophenyl derivatives as selective androgen receptor modulators |
| 09/26/2007 | EP1836196A1 Tricyclic delta-opioid modulators |
| 09/26/2007 | EP1836194A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 09/26/2007 | EP1836179A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 09/26/2007 | EP1836178A1 Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 09/26/2007 | EP1836172A1 5-ht7 receptor antagonists |
| 09/26/2007 | EP1836168A1 Benzoyl-tetrahydropyridine as glyt-1 inhibitors |
| 09/26/2007 | EP1836164A1 11c-labeled benzyl-lactam compounds and their use as imaging agents |
| 09/26/2007 | EP1836154A1 Polymorphs of memantine hydrochloride |
| 09/26/2007 | EP1835924A2 Treatment of parkinson's disease and related disorders using postpartum derived cells |
| 09/26/2007 | EP1835914A1 Sabcomeline alone or combined with a mood stabilising or antimanic agent to treat bipolar disorders |
| 09/26/2007 | EP1835911A2 Therapeutic compositions for intranasal administration of ketorolac |
| 09/26/2007 | EP1835905A2 Use of selected compounds for protection of neurones and oligodendrocytes in the treatment of multiple sclerosis |
| 09/26/2007 | EP1835896A2 Use of certain phenyl napthyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms) |
| 09/26/2007 | EP1835895A2 Use of certain phenyl-naphthyl compounds that do not have significant affintiy to er alpha or beta for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis |
| 09/26/2007 | EP1687293B1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 09/26/2007 | EP1656354B1 Tetrahydroquinazoline derivatives as cfr antagonists |
| 09/26/2007 | EP1656151B1 Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury and proliferation and/or differentiation of neural stem cells in injured spinal cord |
| 09/26/2007 | EP1554250B1 Novel lactams and uses thereof |
| 09/26/2007 | EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 09/26/2007 | EP1474416B1 Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders |
| 09/26/2007 | EP1458708B1 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 09/26/2007 | EP1451153B1 Nk1 antagonists |
| 09/26/2007 | EP1418908B1 Compounds for eliminating and/or relieving anhedonia |
| 09/26/2007 | EP1417173B1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1399141B1 Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy of post-surgical pain |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | EP1322673B1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 09/26/2007 | EP1313481B1 Pharmaceutical composition comprising condensed indole compound |
| 09/26/2007 | EP1261585B1 Substituted indole mannich bases |
| 09/26/2007 | EP1228367B1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
| 09/26/2007 | EP1194447B1 Novel potassium channels and genes encoding these potassium channels |
| 09/26/2007 | EP1140104B1 Treatment of alzheimer's disease by increasing cytidine levels in vivo |
| 09/26/2007 | CN101044144A Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 09/26/2007 | CN101044136A Pyrrolo-naphthyl acids as pai-1 inhibitors |
| 09/26/2007 | CN101044134A Azaspiroalkene and azapiroalkane compounds with nicotinic cholinergic receptor activity |
| 09/26/2007 | CN101043916A Combination of organic compounds |
| 09/26/2007 | CN101043901A Method for preventing and treating alzheimer's disease |
| 09/26/2007 | CN101043891A Therapeutic agents targeting the nc ca-atp channel and methods of use thereof |
| 09/26/2007 | CN101043890A Delta-9-thc for treating symptoms associated with multiple sclerosis |
| 09/26/2007 | CN101043882A Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain |
| 09/26/2007 | CN101041691A Chinese south China sea signal taro snail nerve toxin gene 1t5.4 and uses thereof |
| 09/26/2007 | CN101041629A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 09/26/2007 | CN101041626A Tetrafluorobenzyl derivatives and pharmaceutical composition containing same |
| 09/26/2007 | CN101041063A Polypeptide from faliotidae oral medicine agent and the preparing technique |
| 09/26/2007 | CN101041059A Technique of preparing novel soft capsule for soothing the nerves and providing nutrition for the brain |
| 09/26/2007 | CN101041056A Kawa pills good for brain |
| 09/26/2007 | CN101041055A Anti-alcoholism pill |
| 09/26/2007 | CN101041052A Chinese traditional medicine compound took orally for treating Raynand's disease |
| 09/26/2007 | CN101041018A Chinese traditional medicine took orally for treating cold trigeminal neuralgia |
| 09/26/2007 | CN101041008A Sandong pill |
| 09/26/2007 | CN101040964A Beverage including angelica and dried orange peel for improving sleep quality |
| 09/26/2007 | CN101040929A Method for preparing compound lotus seed oral liquid |
| 09/26/2007 | CN101040918A Chinese traditional medicine good for heart and brain |
| 09/26/2007 | CN101040894A Preparing and application of Yulangsan extract |
| 09/26/2007 | CN101040868A Preparation for regulating release of lithium carbonate, and method for preparing the same |
| 09/26/2007 | CN101040867A Application of fucoidan in the preparation of medicine and health-care products for preventing and treating neurodegenerative diseases |
| 09/26/2007 | CN101040863A Chinese traditional medicine monocase compound for treating alzheimers disease |
| 09/26/2007 | CN101040633A Gastrodia milk powder good for intelligence |
| 09/26/2007 | CN100339379C 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 09/26/2007 | CN100339374C Compounds and methods for modulation of estrogen receptors |
| 09/26/2007 | CN100339356C Aminoadamantane derivatives as therapeutic agents |
| 09/26/2007 | CN100339080C Antiviral compounds |
| 09/26/2007 | CN100339079C Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 09/25/2007 | US7273964 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 09/25/2007 | US7273952 Substituted C-cyclohexylmethylamine derivatives |
| 09/25/2007 | US7273888 Administrating inhibitors of ornithine decarboxylase (involved with synthesis of putrescine; antiproliferative agents |
| 09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
| 09/25/2007 | US7273858 Salts |
| 09/25/2007 | US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273854 Recombinant adenovirus, adeno-associated virus or herpes virus (especially a replication defective virus) containing a nucleic acid of a specific sequence encoding an antisense RNA that inhibits expression of p53. |
| 09/25/2007 | US7273846 Selective melanin-concentrating hormone type-1 receptor agonists |
| 09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273725 Human and mammalian stem cell-derived neuron survival factors |
| 09/25/2007 | US7273712 Methods and compositions for detecting compounds that modulate inflammatory responses |
| 09/25/2007 | US7273698 Defects in periaxin associated with myelinopathies |
| 09/25/2007 | US7273621 Compositions for promoting sleep |
| 09/25/2007 | US7273609 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/25/2007 | CA2376847C Complex of eletriptan and a cyclodextrin derivative |
| 09/25/2007 | CA2372025C Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
| 09/25/2007 | CA2370834C Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders |
| 09/25/2007 | CA2369302C Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol |
| 09/25/2007 | CA2305468C 8-azabicyclo [3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 09/25/2007 | CA2288650C A method for the treatment of mental illness in mammals and a composition therefor |
| 09/25/2007 | CA2243317C Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 09/25/2007 | CA2173592C Stem cell proliferation factor |
| 09/21/2007 | CA2581109A1 Modulator of gamma secretase |
| 09/20/2007 | WO2007106236A2 Pyrrolo-pyridine kinase modulators |
| 09/20/2007 | WO2007106049A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| 09/20/2007 | WO2007105929A1 Synergistic pharmaceutical composition of tramadol and lysine clonixinate |
| 09/20/2007 | WO2007105823A1 Prophylactic/therapeutic agent for alzheimer's disease |
| 09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |